Quality of life in thalassemia: A comparison of SF‐36 results from the thalassemia longitudinal cohort to reported literature and the US norms
Open Access
- 30 September 2010
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 86 (1), 92-95
- https://doi.org/10.1002/ajh.21896
Abstract
Click on the article title to read more.Keywords
This publication has 13 references indexed in Scilit:
- Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overloadAdvances in Therapy, 2008
- Psychosocial aspects and psychiatric disorders in young adult with thalassemia majorInternal and Emergency Medicine, 2008
- Costs, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy: the ITHACA studyCurrent Medical Research and Opinion, 2008
- Clinical and economic burden of infused iron chelation therapy in the United StatesTransfusion, 2007
- Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemiaClinical Therapeutics, 2007
- Survival and Complications in ThalassemiaAnnals of the New York Academy of Sciences, 2005
- Health-Related Quality of Life in Children and Adolescents Who Have a Diagnosis of Attention-Deficit/Hyperactivity DisorderPediatrics, 2004
- Impact of Thalassemia major on Patients and Their FamiliesActa Haematologica, 2002
- The Italian SF-36 Health SurveyJournal of Clinical Epidemiology, 1998
- Effect Sizes for Interpreting Changes in Health StatusMedical Care, 1989